Excipients Supplier Presents ‘Effect of Loaded Dose on Delivered Dose in DPIs’ Poster at RDD Europe

On 22–24 May, DFE Pharma shared its inhalation expertise at the RDD (Respiratory Drug Delivery) Europe event in Berlin to major global stakeholders in the inhalation industry. DFE Pharma presented a poster promoting the latest state of expertise in the field of inhalation lactose.

RDD events are considered leading forums for the global inhalation industry, with participants from multinationals and suppliers to the industry. The presence at RDD Europe provided an excellent opportunity to promote DFE Pharma as a leading inhalation excipient provider and expand both customer base and industrial network.

DFE Pharma expertise was highlighted with a poster titled ‘Effect of Loaded Dose on Delivered Dose in Dry Powder Inhalers’, describing a study done in collaboration with the University of Bath, on how DFE Pharma is investigating the fundamental properties of lactose affecting end product performance.

The poster can be viewed online at: bit.ly/EffectofLoadedDoseonDeliveredDoseinDPIs.

DFE Pharma, +49 2823 9288 770, pharma@dfepharma.com, www.dfepharma.com.